Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer. by Yuen, J, Macaulay, V

The type 1 insulin-like growth factor receptor pathway. by Chitnis, M, Yuen, J, Protheroe, A, Pollak, M, Macaulay, V

Dendritic Cells: Cellular Mediators for Immunological Tolerance by Chun Yuen J. Chung, Dirk Ysebaert, Zwi N. Berneman, Nathalie Cools

Get full text

Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer. by Yuen, J, Akkaya, E, Wang, Y, Takiguchi, M, Peak, S, Sullivan, M, Protheroe, A, Macaulay, V

Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer by Yuen, J, Akkaya, E, Wang, Y, Takiguchi, M, Peak, S, Sullivan, M, Protheroe, A, Macaulay, V

The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma. by Yuen, J, Cockman, M, Sullivan, M, Protheroe, A, Turner, G, Roberts, I, Pugh, C, Werner, H, Macaulay, V